超声电导仪透药治疗包裹性结核性胸膜炎疗效分析

Analysis of curative effect of intra-tissue electrophonophoresis in the treatment of tuberculous encysted pleurisy

目的:评价全身抗结核治疗基础上联合超声电导仪透药治疗包裹性结核性胸膜炎的临床疗效。方法:将62例初治包裹粘连分隔的结核性胸膜炎患者随机分为治疗组31例及对照组31例,对照组患者采取全身抗结核治疗,治疗组在全身抗结核基础上加用超声电导仪透入抗结核药物和尿激酶治疗。结果:治疗15d及30d后,治疗组总有效率分别为77.42%、93.55%,明显高于对照组54.84%、74.19%,差异有统计学意义(P<0.05)。且治疗组粘连分隔明显减轻,两组均没有严重不良反应。结论:超声电导仪透药辅助治疗结核性包裹性胸膜炎可以明显提高胸水的吸收,减轻粘连分隔。

Objective： Evaluation based on the systemic anti-tuberculosis treatment combined intra-tissue electrophonophoresis treatment of the clinical effect of tuberculous encysted plenritis. Methods： 62 patients treated first parcel adhesion of tuberculous pleurisy patients were randomly divided into treatment group 31 cases and control group in 31 cases, control group patients take systemic anti-tuberculosis treatment, treatment group on the basis of systemic anti-tuberculosis used intra-tissue electrophonophoresis instrument penetration anti-tb drugs and urokinase therapy. Results： 15 days and 30 days after treatment, the treatment group total effective rate were 77.42%, 93.55%, significantly higher than that of control group were 54.84%, 74.19%, the difference was statistically significant （P^0.05）. And adhesion separation treatment group was obviously relieve, two groups were no serious adverse reactions. Conclusion： electrophonophoresis with antituberculosis drugs and urokinase treat tuberculous encysted pleurisy can obviously increase the water absorption, reduce adhesion separation.